Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves

被引:3
作者
Mauricio, Didac [1 ,2 ,3 ,4 ]
Vlacho, Bogdan [1 ,2 ]
Ortega, Emilio [1 ,5 ,6 ,7 ]
Cos-Claramunt, Xavier [1 ,8 ,9 ]
Mata-Cases, Manel [1 ,2 ,10 ]
Real, Jordi [1 ,2 ]
Fernandez-Camins, Berta [1 ,11 ]
Franch-Nadal, Josep [1 ,2 ,7 ,12 ]
机构
[1] Fundacio Inst Univ Recerca Atencio Primaria Salut, Unitat Suport Recerca Barcelona, DAP Cat Grp, Barcelona, Spain
[2] Inst Salud Carlos III ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain
[3] Hosp Univ Santa Creu & St Pau, Dept Endocrinol & Nutr, Barcelona, Spain
[4] Cent Univ Catalonia, Univ Vic, Dept Med, Barcelona, Spain
[5] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Suner, Dept Endocrinol & Nutr, Barcelona, Spain
[6] Inst Salud Carlos III ISCIII, CIBER Physiopathol Obes & Nutr CIBEROBN, Madrid, Spain
[7] Univ Barcelona, Dept Med, Barcelona, Spain
[8] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
[9] Inst Catala Salut, Innovat Off, Barcelona, Spain
[10] Inst Catala Salut, Gerencia Ambit Atencio Primaria Barcelona Ciutat, Primary Hlth Care Ctr La Mina, St Adria De Besos, Spain
[11] Inst Catala Salut, Gerencia Ambit Atencio Primaria Barcelona Ciutat, Primary Hlth Care Ctr Poblenou, St Adria De Besos, Spain
[12] Inst Catala Salut, Gerencia Ambit Atencio Primaria Barcelona Ciutat, Primary Hlth Care Ctr Raval Sud, St Adria De Besos, Spain
关键词
Diabetes mellitus; COVID-19; Catalonia; Epidemiological wave; Obesity; Primary care; SARS-COV-2; MORTALITY; RISK;
D O I
10.1016/j.pcd.2022.12.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: We estimate the incidence and risk factors for fatal and non-fatal events among the COVID-19 infected subjects based on the presence of obesity or diabetes during the initial three epidemiological waves in our region. Methods: This was a retrospective cohort study. A primary care database was used to identify persons with COVID-19. We stratified for subjects who either had diabetes mellitus or obesity. The follow-up period for study events was up to 90 days from inclusion. Results: In total, 1238,710 subjects were analysed. Subjects with diabetes mellitus or obesity were older and had a worse comorbidity profile compared with groups without these conditions. Fatal events were more frequent among people with diabetes and during the first wave. In the second and third waves, the number of study events decreased. Diabetes was a risk factor for fatal events in all models, while obesity was only in the model adjusted for age, sex, diabetes and COVID-19 waves. HIV, cancer, or autoimmune diseases were risk factors for mortality among subjects with COVID-19 in the fully-adjusted model. Conclusions: Diabetes was an independent risk factor for mortality among people with COVID-19. The number of fatal events decreased during the second and third waves in our region, both in those with diabetes or obesity.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 40 条
[11]   Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain) [J].
Giner-Soriano, Maria ;
Gomez-Lumbreras, Ainhoa ;
Vedia, Cristina ;
Ouchi, Dan ;
Morros, Rosa .
BMC PRIMARY CARE, 2022, 23 (01)
[12]   Diabetes is a risk factor for the progression and prognosis of COVID-19 [J].
Guo, Weina ;
Li, Mingyue ;
Dong, Yalan ;
Zhou, Haifeng ;
Zhang, Zili ;
Tian, Chunxia ;
Qin, Renjie ;
Wang, Haijun ;
Shen, Yin ;
Du, Keye ;
Zhao, Lei ;
Fan, Heng ;
Luo, Shanshan ;
Hu, Desheng .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (07)
[13]   COVID-19 Immunobiology: Lessons Learned, New Questions Arise [J].
Kaklamanos, Aimilios ;
Belogiannis, Konstantinos ;
Skendros, Panagiotis ;
Gorgoulis, Vassilis G. G. ;
Vlachoyiannopoulos, Panayiotis G. G. ;
Tzioufas, Athanasios G. G. .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[14]   Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis [J].
Kyriazopoulou, Evdoxia ;
Leventogiannis, Konstantinos ;
Norrby-Teglund, Anna ;
Dimopoulos, Georgios ;
Pantazi, Aikaterini ;
Orfanos, Stylianos E. ;
Rovina, Nikoletta ;
Tsangaris, Iraklis ;
Gkavogianni, Theologia ;
Botsa, Elektra ;
Chassiou, Eleftheria ;
Kotanidou, Anastasia ;
Kontouli, Christina ;
Chaloulis, Panagiotis ;
Velissaris, Dimitrios ;
Savva, Athina ;
Cullberg, Jonas-Sunden ;
Akinosoglou, Karolina ;
Gogos, Charalambos ;
Armaganidis, Apostolos ;
Giamarellos-Bourboulis, Evangelos J. .
BMC MEDICINE, 2017, 15
[15]   Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis [J].
Li, Xinyang ;
Zhong, Xianrui ;
Wang, Yongbo ;
Zeng, Xiantao ;
Luo, Ting ;
Liu, Qing .
PLOS ONE, 2021, 16 (05)
[16]   Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis [J].
Longmore, Danielle K. ;
Miller, Jessica E. ;
Bekkering, Siroon ;
Saner, Christoph ;
Mifsud, Edin ;
Zhu, Yanshan ;
Saffery, Richard ;
Nichol, Alistair ;
Colditz, Graham ;
Short, Kirsty R. ;
Burgner, David P. .
DIABETES CARE, 2021, 44 (06) :1281-1290
[17]   Diabetes Mellitus and Inflammation [J].
Lontchi-Yimagou, Eric ;
Sobngwi, Eugene ;
Matsha, Tandi E. ;
Kengne, Andre Pascal .
CURRENT DIABETES REPORTS, 2013, 13 (03) :435-444
[18]   Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies [J].
Mahamat-Saleh, Yahya ;
Fiolet, Thibault ;
Rebeaud, Mathieu Edouard ;
Mulot, Matthieu ;
Guihur, Anthony ;
El Fatouhi, Douae ;
Laouali, Nasser ;
Peiffer-Smadja, Nathan ;
Aune, Dagfinn ;
Severi, Gianluca .
BMJ OPEN, 2021, 11 (10)
[19]   Evaluation of clinical and antidiabetic treatment characteristics of different sub-groups of patients with type 2 diabetes: Data from a Mediterranean population database [J].
Mata-Cases, Manel ;
Franch-Nadal, Josep ;
Real, Jordi ;
Vlacho, Bogdan ;
Gomez-Garcia, Anton ;
Mauricio, Didac .
PRIMARY CARE DIABETES, 2021, 15 (03) :588-595
[20]  
Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8